In an interview with Fortune, Hoffman discussed the thorny societal questions surrounding AI, as well as his own experiences as a founder, and funder, of AI startups including OpenAI.
Reid Hoffman is a Partner at Greylock Partners and Co-Founder and Executive Chairman at LinkedIn (NYSE: LNKD). Reid joined Greylock Partners in 2009. His areas of focus include consumer Internet, enterprise 2.
LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in the shadow of Stanford University, where he and fellow technology luminary Peter Thiel became friends as college students during the 1980s.
In his new book, LinkedIn's Reid Hoffman argues that fear-focused responses to AI ignore the incredible promise this technological revolution holds.
Reid Hoffman, the co-founder of LinkedIn and a member of the 'PayPal Mafia,' has been deeply involved in Silicon Valley's technological advancements. He remains optimistic about AI's potential despite widespread concerns.
Reid Hoffman, co-founder of LinkedIn and member of the “PayPal Mafia,” has shared his verdict on Elon Musk’s “supernova burnout” personality on The Daily Beast Podcast. Having worked together at PayPal and OpenAI,
Techno-optimist, investor and LinkedIn co-founder Reid Hoffman has written a new book, “Superagency,” outlining his vision of an AI-powered future. On Wednesday, Feb. 5 T, Hoffman joins The Post’s Bina Venkataraman to discuss how AI could help address the world’s most urgent problems and the future of human agency in the AI era.
We’re producing vastly more information than any of us can possibly consume—artificial intelligence may be the key to effectively making use of that data.
LinkedIn founder Reid Hoffman shares his optimistic views on AI's future and discusses insights from his new book, 'Superagency', amidst tech industry concerns.
LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an
Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.
The LinkedIn co-founder is starting Manas AI with “The Emperor of All Maladies” author Siddhartha Mukherjee.